Concepedia

Author

Johnathan C. Maher

University of Miami

Also Known As

J. Maher, Johnathan C Maher, Johnathan C. Maher, Johnathan Cartwright Maher, Johnathan Maher

30

Publications

1.1K

Citations

10

H-Index

11

Concepts

All Affiliations

University of MiamiSylvester Comprehensive Cancer Center
JC

About

Johnathan C. Maher is an author at University of Miami specializing in cancer research, tumor biology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

280

2

Biochemistry

1

1

76

3

Cell Biology

1

1

204

4

Metabolism

1

1

204

5

Pharmacology

1

1

76

Johnathan C. Maher

×

9

Publications

869

Citations

9

H-Index

YearCitations

Under normoxia, 2-deoxy-<scp>d</scp>-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation

Metin Kurtoğlu, Ningguo Gao, Jie Shang,

Molecular Cancer Therapeutics

2007

239

Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-d-glucose in tumor cells treated under hypoxic vs aerobic conditions

Johnathan C. Maher, Awtar Krishan, Théodore J. Lampidis

Cancer Chemotherapy and Pharmacology

2004

204

Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-<scp>d</scp>-glucose

Johnathan C. Maher, Medhi Wangpaichitr, Niramol Savaraj,

Molecular Cancer Therapeutics

2007

106

Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial

Emmanuel S. Antonarakis, Adam S. Kibel, Evan Y. Yu,

Clinical Cancer Research

2016

77

Efficacy of 2-halogen substituted d-glucose analogs in blocking glycolysis and killing “hypoxic tumor cells”

Théodore J. Lampidis, Metin Kurtoğlu, Johnathan C. Maher,

Cancer Chemotherapy and Pharmacology

2006

76

N′1,N′3-Dimethyl-N′1,N′3-bis(phenylcarbonothioyl) Propanedihydrazide (Elesclomol) Selectively Kills Cisplatin Resistant Lung Cancer Cells through Reactive Oxygen Species (ROS)

Medhi Wangpaichitr, Chunjing Wu, Min You,

Cancers

2009

70

Differential Sensitivity to 2-Deoxy-D-glucose Between Two Pancreatic Cell Lines Correlates With GLUT-1 Expression

Johnathan C. Maher, Niramol Savaraj, Waldemar Priebe,

Pancreas

2005

46

Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy- <scp>d</scp> -glucose under hypoxia in lung cancer cell lines

Medhi Wangpaichitr, Niramol Savaraj, Johnathan C. Maher,

Molecular Cancer Therapeutics

2008

33

An Analysis of Leukapheresis and Central Venous Catheter Use in the Randomized, Placebo Controlled, Phase 3 IMPACT Trial of Sipuleucel-T for Metastatic Castrate Resistant Prostate Cancer

Robert C. Flanigan, Anthony Polcari, N. Shore,

The Journal of Urology

2012

18

Page 1